Hyperlipidemia, familial combined, LPL related: genes and variants
Explore variant evidence for Hyperlipidemia, familial combined, LPL related across 1 analyzed protein (LPL). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hyperlipidemia, familial combined, LPL related
LPL: Lipoprotein lipase
It hydrolyzes triglycerides in circulating chylomicrons and very-low-density lipoproteins so tissues can take up released fatty acids. Severe biallelic loss causes familial chylomicronemia, while common variation strongly influences triglyceride levels and cardiovascular risk.
18 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in LPL have source records linked to Hyperlipidemia, familial combined, LPL related. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Hyperlipidemia, familial combined, LPL related
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LPL H268Y | 268 | Pathogenic / likely pathogenic (★★) | |
| LPL W113R | 113 | Pathogenic / likely pathogenic (★★) | |
| LPL R270C | 270 | Pathogenic / likely pathogenic (★★) | |
| LPL D183N | 183 | Pathogenic / likely pathogenic (★★) | |
| LPL P234L | 234 | Pathogenic / likely pathogenic (★★) | |
| LPL A98T | 98 | Pathogenic / likely pathogenic (★★) | |
| LPL G215E | 215 | Pathogenic / likely pathogenic (★★) | |
| LPL I252T | 252 | Essential for determining substrate specificity | Pathogenic / likely pathogenic (★★) |
| LPL L279V | 279 | Pathogenic / likely pathogenic (★★) | |
| LPL M328I | 328 | Pathogenic / likely pathogenic (★★) | |
| LPL M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| LPL D277N | 277 | Pathogenic / likely pathogenic (★★) | |
| LPL C302R | 302 | Pathogenic / likely pathogenic (★) | |
| LPL C310Y | 310 | Pathogenic / likely pathogenic (★) | |
| LPL G436R | 436 | PLAT | Pathogenic / likely pathogenic (★) |
| LPL D231N | 231 | Pathogenic / likely pathogenic (★) | |
| LPL A361T | 361 | PLAT | Pathogenic / likely pathogenic (★) |
| LPL R197H | 197 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Hyperlipidemia, familial combined, LPL related
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| LPL H268Q | 268 | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; H268Y at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.892 |
Same protein, different disease
- Hyperlipoproteinemia also has ClinVar records linked to LPL variants; they fall partly in the same places as the Hyperlipidemia, familial combined, LPL related variants (44 pathogenic / likely pathogenic).
Diseases related to Hyperlipidemia, familial combined, LPL related
- Type 2 diabetes mellitus, also linked to LPL
- Hyperlipoproteinemia, also linked to LPL
- Myocardial infarction, also linked to LPL
Frequently asked questions
Which genes have records linked to Hyperlipidemia, familial combined, LPL related?
This view contains 1 analyzed proteins: LPL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 40 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center